AI Terminal
KROPZ PLC
Capital/Financing Update • Oct 10, 2024
7754_rns_2024-10-10_8fd06e33-3151-4285-ab43-fdc6a8060053.html
Capital/Financing Update
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 7640H
Kropz PLC
10 October 2024
10 October 2024
Kropz plc
("Kropz" or the "Company")
Receipt of Exchange Control Approval
Kropz plc (AIM: KRPZ), an emerging African phosphate producer, is pleased to announce that it has received approval from the South African Reserve Bank ("Exchange Control Approval") in relation to the Restructuring, Fundraising and the issue of the Convertible Loan Notes as announced on 3 September 2024.
Consequently, as shareholder approval was obtained at the General Meeting ("GM") on 20 September 2024, the Restructuring, Fundraising and the issue of the Convertible Loan Notes is now wholly unconditional.
An application has been made for the 643,873,018 new Ordinary Shares ("New Ordinary Shares") pursuant to the Fundraising to be admitted to trading on AIM ("Admission") and a further announcement will be made in due course to confirm the commencement date and time of dealings in respect of the New Ordinary Shares.
For further information visit www.kropz.com or contact:
| Kropz Plc | Via Tavistock |
| Louis Loubser (CEO) | +44 (0) 207 920 3150 |
| Grant Thornton UK LLP | Nominated Adviser |
| Samantha Harrison Harrison Clarke Ciara Donnelly |
+44 (0) 20 7383 5100 |
| Hannam & Partners | Broker |
| Andrew Chubb Ernest Bell |
+44 (0) 20 7907 8500 |
| Tavistock | Financial PR & IR (UK) |
| Nick Elwes Jos Simson |
+44 (0) 207 920 3150 [email protected] |
| R&A Strategic Communications | PR (South Africa) |
| Charmane Russell Marion Brower |
+27 (0) 11 880 3924 [email protected] [email protected] |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCEBLFFZBLLFBV